Company Overview

Update
Founded:
2006
Founders:
Fred Khosravi
Headquarters:
Bedford, MA
IPO:
Went Public on Jul 15, 2014
Stock:
OCUL
Categories:
Biotechnology
Description:
Ocular Therapeutix develops and commercializes ophthalmic therapeutic products by using hydrogel technology.

Detailed Description

Update

Ocular Therapeutix, Inc. engages in the development and commercialization of ophthalmic therapeutic products using its proprietary hydrogel technology to address unmet or underserved needs in ophthalmology. Its products include ReSure Adherent Ocular Bandage, a synthetic ocular bandage for ophthalmic surgery; ReSure Sealant, a synthetic and biocompatible hydrogel that creates a temporary, soft, and lubricious surface barrier to protect clear corneal incisions in the immediate post-operative period; and prostaglandin analog punctum plugs that are hydrogel-based punctum plug depots to deliver prostaglandin analogs to treat glaucoma.

Current Team (2)

Update

Past Team (1)

Update

Funding Rounds (6) - $73.3M

Update

Board Members and Advisors (2)

Update

Investors (5)

Update

Offices/Locations (1)

Update
  • Office

    36 Crosby Drive,

    Suite 101,

    Bedford, MA 01730

    USA

Images (1)

Update
  • B9d6a0dd3ca9d2006ad5490218771d3b